NCT05925192

Brief Summary

Lack of adherence is one of the main problems of chronic musculoskeletal pain treatment. To improve adherence it is essential to take into account the characteristics of the patients and their thoughts and beliefs about pain. Virtual reality can present some advantages in the face of these problems too. The objective of this study is to evaluate the profile of chronic musculoskeletal pain patients, the barriers associated with lack of adherence to treatment, and the interest of virtual reality in rehabilitation.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started Jun 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Jun 2023Sep 2026

First Submitted

Initial submission to the registry

June 21, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 29, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

June 30, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Expected
Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

1.3 years

First QC Date

June 21, 2023

Last Update Submit

April 29, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Pain Intensity

    To assess pain intensity using the verbal numeric pain scale. Scores range from 0 (no pain) to 10 (worst pain imaginable). Higher scores indicate greater intensity.

    Baseline

  • Pain Intensity and chronic pain interference

    To assess pain intensity and chronic pain interference using the graded chronic pain scale. Scores range from 0 (no pain/no interference) to 10 (worst pain imaginable/unable to carry on any activities). Higher scores indicate greater intensity or interference.

    Baseline

  • Pain Severity

    To assess pain severity using the brief pain inventory. Scores range from 0 (no pain/does not interfere) to 10 (worst pain imaginable/completely interferes). Higher scores indicate greater severity.

    Baseline

  • Awareness, Consciousness, Vigilance and Observation of pain

    To assess awareness, consciousness, vigilance and observation of pain using the pain vigilance and awareness questionnaire. Scores range from 0 (never) to 5 (always). The total questionnaire scores range between 0 and 80. Higher scores indicate greater awareness, consciousness, vigilance and observation of pain.

    Baseline

  • Chronic Pain Acceptance

    To assess chronic pain acceptance using the chronic pain acceptance questionnaire. Scores range from 0 (never true) to 6 (it is always true). Higher scores indicate greater acceptance.

    Baseline

  • Neurophysiology of Pain

    To assess neurophysiology of pain using the neurophysiology of pain questionnaire. Scores range from 0 to 13 (sum of all correct items).

    Baseline

Secondary Outcomes (14)

  • Kinesiophobia

    Baseline

  • Catastrophizing of pain

    Baseline

  • Functionality

    Baseline

  • Disability

    Baseline

  • Level of movement related to space

    Baseline

  • +9 more secondary outcomes

Study Arms (1)

Chronic musculoskeletal pain patients

Chronic musculoskeletal pain patients

Other: Observational study

Interventions

N/A - observational study

Chronic musculoskeletal pain patients

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chronic musculoskeletal pain patients

You may qualify if:

  • Chronic musculoskeletal pain (≥ 3 months)
  • Adults (≥ 18 years)
  • Have a computer or mobile device/Basic knowledge and access to the internet
  • Wish to participate in the study and sign the informed consent

You may not qualify if:

  • All those participants who present any physical pathology or of any kind that imply an inability to understand the necessary instructions to carry out the study will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Granada

Granada, Granada, Spain

Location

MeSH Terms

Interventions

Observation

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Irene Torres Sánchez, PhD

    Universidad de Granada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, PhD, Principal investigator

Study Record Dates

First Submitted

June 21, 2023

First Posted

June 29, 2023

Study Start

June 30, 2023

Primary Completion

September 30, 2024

Study Completion (Estimated)

September 30, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Locations